Press Release

Kelsey Stevens Named CEO of Wakely Consulting Group

Issued by Wakely Consulting Group

Jan. 16, 2025

We are pleased to announce that Kelsey Stevens, principal at Wakely Consulting Group, an HMA Company, has been named the new chief executive officer (CEO) of Wakely. Kelsey succeeds Mary Hegemann, who recently was promoted to executive vice president at HMA.

A respected and trusted leader, Kelsey has been an integral part of Wakely since 2012, fostering a culture of collaboration, innovation, and excellence. As a champion for both internal teams and client solutions, she has guided Wakely through complex challenges and significant growth. Her leadership combines a deep understanding of healthcare markets with technical expertise and strategic vision, ensuring the continued delivery of exceptional results for clients.

“I’m deeply honored to take on this role and excited for the future of Wakely. Our work has always been about empowering clients with innovative, data-driven solutions, and with the support of our HMA family, we’re uniquely positioned to make an even greater impact,” Kelsey said. “I look forward to collaborating with our incredible team as we navigate the challenges and opportunities of an evolving healthcare landscape.”

With over 18 years of experience in the healthcare field, Kelsey brings expertise in pricing, and rate development, regulatory filings, product design, and financial forecasting. She has worked extensively with health plans, providers, and government agencies across both commercial and government programs, including supporting several accountable care organizations participating in CMS and CMMI programs. She is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries.

Kelsey will continue to work out of the company’s Tampa Bay, Fla., office.

Editor's note: This press release has been issued by the company named above, not BenefitsLink. Reliance on information in this press release might be prudent only after an independent review of its accuracy, completeness, efficacy, and timeliness. Reference to any specific commercial product, process, or service by trade name, trademark, service mark, manufacturer, or otherwise does not constitute or imply endorsement, recommendation, or favoring by BenefitsLink.